共 107 条
- [1] Barrasa-Villar JI(2017)Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms Clin Infect Dis 15 644-652
- [2] Aibar-Remón C(2018)Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Lancet Infect Dis 18 318-327
- [3] Prieto-Andrés P(2020)New β-lactam-β-lactamase inhibitor combinations Clin Microbiol Rev 34 1-61
- [4] Mareca-Doñate R(2017)Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance FEMS Microbiol Rev 41 252-275
- [5] Moliner-Lahoz J(2015)Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance Antimicrob Agents Chemother 59 5873-5884
- [6] Tacconelli E(2009)Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms Clin Microbiol Rev 22 582-610
- [7] Carrara E(2019)Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution Drug Resist Updat 44 100640-976
- [8] Savoldi A(2010)Updated functional classification of beta-lactamases Antimicrob Agents Chemother 54 969-2290
- [9] Harbarth S(2013)Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa J Antimicrob Chemother 68 2286-4308
- [10] Mendelson M(2020)A clinical review and critical evaluation of imipenem-relebactam: evidence to date Infect Drug Resist 13 4297-1808